These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8935701

  • 1. [Implantable cardioverter defibrillator. New therapeutic option to malignant ventricular arrhythmias].
    Halperin C, Costa R, Lucchese FA.
    Arq Bras Cardiol; 1996 Mar; 66 Suppl 1():59-62. PubMed ID: 8935701
    [No Abstract] [Full Text] [Related]

  • 2. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

  • 3. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 4. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK, Mehta D, Gomes JA.
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [Abstract] [Full Text] [Related]

  • 5. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH, Gold MR.
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [Abstract] [Full Text] [Related]

  • 6. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [Abstract] [Full Text] [Related]

  • 7. [Implantable cardioverter-defibrillator: prevention of sudden cardiac death and impact on survival in patients with malignant ventricular arrhythmias].
    Occhetta E, Magnani A, Francalacci G, Perucca A, Sarasso G, Piccinino C, Trevi G.
    Cardiologia; 1995 Jun; 40(6):419-25. PubMed ID: 8640855
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S, Murawski MM.
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA, Turner JW, Dec GW.
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [Abstract] [Full Text] [Related]

  • 18. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
    Thakor NV, Natarajan A.
    Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
    [Abstract] [Full Text] [Related]

  • 19. [Defibrillators--end of sudden cardiac death?].
    Kozák M.
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S63-7. PubMed ID: 15651143
    [Abstract] [Full Text] [Related]

  • 20. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
    European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):e247-346. PubMed ID: 16949478
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.